Drug Repurposing Hub specifications


Unique identifier OMICS_17384
Name Drug Repurposing Hub
Restrictions to use None
Community driven No
Data access File download
User data submission Not allowed
Maintained Yes


  • person_outline Todd Golub

Publication for Drug Repurposing Hub

Drug Repurposing Hub institution(s)
Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA
Drug Repurposing Hub funding source(s)
This work was supported in part by NIH LINCS Program grants 3U54 HG006093, U54 HL127366, and U54 HG008699, the Howard Hughes Medical Institute, NIH training grant T32 CA009172, KL2/Catalyst Medical Research Investigator Training award from Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) Award KL2 TR001100 and the Conquer Cancer Foundation of ASCO Young Investigator Award.

Drug Repurposing Hub reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Drug Repurposing Hub